Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996

Biochemical and Biophysical Research Communications

Volumn 419, Issue 4, 2012, Pages 728-734

  Li, Xin xing ^a   Wang, Jian ^a   Wang, Hao lu ^a   Wang, Wei ^a   Yin, Xiao bin ^a   Li, Qi wei ^a   Chen, Yu ying ^b   Yi, Jing ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cancer stem cell; Gallbladder carcinoma; Side population cell

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL INVASION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL STRUCTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GALLBLADDER CARCINOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SGC 996 CELL; SIDE POPULATION CELL;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GALLBLADDER NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862779042     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.090     Document Type: Article

References (30)

1. Gourgiotis S., Kocher H.M., Solaini L., Yarollahi A., Tsiambas E., Salemis N.S. Gallbladder cancer. Am. J. Surg. 2008, 196:252-264.
2. Misra S., Chaturvedi A., Misra N.C., Sharma I.D. Carcinoma of the gallbladder. Lancet Oncol. 2003, 4:167-176.
3. Valle J., Wasan H., Palmer D.H., Cunningham D., Anthoney A., Maraveyas A., Madhusudan S., Iveson T., Hughes S., Pereira S.P., Roughton M., Bridgewater J. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 2010, 362:1273-1281.
4. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
5. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
6. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Nat. Acad. Sci. USA 2003, 100:15178-15183.
7. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
8. Takaishi S., Okumura T., Tu S.P., Wang S.S.W., Shibata W., Vigneshwaran R., Gordon S.A.K., Shimada Y., Wang T.C. Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44. Stem Cells 2009, 27:1006-1020.
9. Moserle L., Ghisi M., Amadori A., Indraccolo S. Side population and cancer stem cells: therapeutic implications. Cancer Lett. 2010, 288:1-9.
10. Ishii H., Iwatsuki M., Ieta K., Ohta D., Haraguchi N., Mimori K., Mori M. Cancer stem cells and chemoradiation resistance. Cancer Sci. 2008, 99:1871-1877.
11. Ding X.W., Wu J.H., Jiang C.P. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010, 86:631-637.
12. Schwabedissen H.E., Kroemer H.K. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters BCRP/MXR/ABCP/ABCG2. Handb. Exp. Pharmacol. 2011, 201:325-371.
13. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
14. Huang D., Gao Q., Guo L., Zhang C., Jiang W., Li H., Wang J., Han X., Shi Y., Lu S.H. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev. 2009, 18:465-473.
15. Fukaya R., Ohta S., Yamaguchi M., Fujii H., Kawakami Y., Kawase T., Toda M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett. 2010, 291:150-157.
16. Wu C., Alman B.A. Side population cells in human cancers. Cancer Lett. 2008, 268:1-9.
17. Huang X.Z., Wang J., Huang C., Chen Y.Y., Shi G.Y., Hu Q.S., Yi J. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biol. Ther. 2008, 7:468-475.
18. Ailles L.E., Weissman I.L. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 2007, 18:460-466.
19. Spillane J.B., Henderson M.A. Cancer stem cells: a review. ANZ. J. Surg. 2007, 77:464-468.
20. Eyler C.E., Rich J.N. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol. 2008, 26:2839-2845.
21. Bomken S., Fiser K., Heidenreich O., Vormoor J. Understanding the cancer stem cell. Br. J. Cancer 2010, 103:439-445.
22. Sengupta A., Cancelas J.A. Cancer stem cells: a stride towards cancer cure?. J. Cell Physiol. 2010, 225:7-14.
23. Wang W., Sun Y.P., Huang X.Z., He M., Chen Y.Y., Shi G.Y., Li H., Yi J., Wang J. Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation. Biochem. Pharmacol. 2010, 79:1134-1140.
24. Tabor M.H., Clay M.R., Owen J.H., Bradford C.R., Carey T.E., Wolf G.T., Prince M.E. Head and neck cancer stem cells: the side population. Laryngoscope 2011, 121:527-533.
25. Shi G.M., Xu Y., Fan J., Zhou J., Yang X.R., Qiu S.J., Liao Y., Wu W.Z., Ji Y., Ke A.W., Ding Z.B., He Y.Z., Wu B., Yang G.H., Qin W.Z., Zhang W., Zhu J., Min Z.H., Wu Z.Q. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J. Cancer Res. Clin. Oncol. 2008, 134:1155-1163.
26. Wan G., Zhou L., Xie M., Chen H., Tian J. Characterization of side population cells from laryngeal cancer cell lines. Head Neck 2010, 32:1302-1309.
27. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., Brenner M.K. A distinct " side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 2004, 101:14228-14233.
28. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., Maclaughlin D.T., Donahoe P.K. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc. Natl. Acad. Sci. USA 2006, 103:11154-11159.
29. Yang M., Zhang R., Yan M., Ye Z., Liang W., Luo Z. Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro. Biochem. Biophys. Res. Commun. 2010, 391:1062-1066.
30. Ni Z., Bikadi Z., Rosenberg M.F., Mao Q. Structure and function of the human breast cancer resistance protein BCRP/ABCG2. Curr. Drug Metab. 2010, 11:603-617.